Overview

ALK29-002: A Study of Baclofen Formulations in Healthy Adults

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics, safety, and tolerability of different baclofen formulations.
Phase:
Phase 1
Details
Lead Sponsor:
Alkermes, Inc.
Treatments:
Baclofen